Welcome to the InfoSci Platform
Reference Hub1
Measurement Methodologies for Assessing the Glycolysis Effect in the Discrimination and Therapy of Brain Gliomas

Measurement Methodologies for Assessing the Glycolysis Effect in the Discrimination and Therapy of Brain Gliomas

Michalis G. Kounelakis, Ekaterini S. Bei, Michalis E. Zervakis, Georgios C. Giakos, Lin Zhang, Chaya Narayan, Dimitrios Kafetzopoulos
Copyright: © 2013 |Volume: 1 |Issue: 1 |Pages: 22
ISSN: 2166-7241|EISSN: 2166-725X|EISBN13: 9781466631847|DOI: 10.4018/ijmstr.2013010103
Cite Article Cite Article

MLA

Kounelakis, Michalis G., et al. "Measurement Methodologies for Assessing the Glycolysis Effect in the Discrimination and Therapy of Brain Gliomas." IJMSTR vol.1, no.1 2013: pp.34-55. http://doi.org/10.4018/ijmstr.2013010103

APA

Kounelakis, M. G., Bei, E. S., Zervakis, M. E., Giakos, G. C., Zhang, L., Narayan, C., & Kafetzopoulos, D. (2013). Measurement Methodologies for Assessing the Glycolysis Effect in the Discrimination and Therapy of Brain Gliomas. International Journal of Monitoring and Surveillance Technologies Research (IJMSTR), 1(1), 34-55. http://doi.org/10.4018/ijmstr.2013010103

Chicago

Kounelakis, Michalis G., et al. "Measurement Methodologies for Assessing the Glycolysis Effect in the Discrimination and Therapy of Brain Gliomas," International Journal of Monitoring and Surveillance Technologies Research (IJMSTR) 1, no.1: 34-55. http://doi.org/10.4018/ijmstr.2013010103

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Primary brain tumors refer to those developing from the various types of cells that compose the brain. Gliomas represent about 50% of all primary brain tumors and include a variety of different histological tumor types and malignancy grades. The World Health Organization (WHO) classifies gliomas into four histological types and four grades. The goal of molecular classification using advanced pattern recognition tools is to identify subgroups of tumors with distinct biological and clinical features and initiate the challenge of classifying complex gliomas of similar histology and malignancy status into distinct categories. The aim of this paper is to i) present the measurement procedures and analysis methodologies, ii) summarize the currently available knowledge related to the utilization of ’omics’ measurements in the discrimination of brain gliomas, and iii) provide a scientific basis for future medical practice in the discrimination and treatment of brain gliomas based specifically on the metabolic process of glycolysis. In particular, the paper explores the idea of the glycolysis pathway as a critical concept for the development of therapeutic strategies for brain gliomas.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.